课题基金 / 基金详情

New Boron and Gadolinium Agents for Neutron Capture Therapy

New Boron and Gadolinium Agents for Neutron Capture Therapy
用于中子捕获治疗的新型硼和钆剂
批准号:
DP0986055
负责人:
Prof Louis Rendina
金额:
$28.36万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2009
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2009-07-01 至 2012-12-31

项目摘要

项目成果

Prof Louis Rendina的其他基金

相似基金

相关文献

中文摘要
翻译
开发新的癌症药物和治疗方法对改善健康结果和社区福祉非常重要。这项研究有可能导致新的抗癌药物的开发,这将极大地扩大一种治疗高度侵袭性肿瘤的有希望的临床疗效。这项研究的创新性质也将有助于澳大利亚的科学知识基础,这是其未来经济繁荣的关键因素,它将为年轻研究人员在迅速扩大的药物设计和开发领域的就业提供优秀的培训。
英文摘要
The development of new drugs and treatments for cancer is highly important for improved health outcomes and the well-being of the community. This research has the potential to result in the development of new anticancer pharmaceuticals that will dramatically expand the clinical efficacy of a promising treatment for highly aggressive tumours. The innovative nature of this research will also contribute to Australia's science knowledge base, a key element in its future economic prosperity, and it will provide excellent training of young researchers for employment in the rapidly expanding field of drug design and development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial targeting by a new class of gadolinium agents
  • 批准号:
    DP190103461
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $29.49万
  • 财政年份:
    2019
  • 负责人:
    Prof Louis Rendina
  • 依托单位:
Platinum-Carborane Complexes as New Agents for Boron Neutron Capture Therapy
  • 批准号:
    DP0557118
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $20.1万
  • 财政年份:
    2005
  • 负责人:
    Prof Louis Rendina
  • 依托单位:
DNA Nanoshuttles: A New Class of DNA-Binding Molecules
  • 批准号:
    DP0557235
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $35.39万
  • 财政年份:
    2005
  • 负责人:
    Prof Louis Rendina
  • 依托单位:
海外基金